• Skip to main content
  • Skip to footer
Eco Friendly CBD OIL

Eco Friendly CBD OIL

The Best Eco Friendly CBD Oil

  • Home
  • CBD Health
  • Cannabis News
  • Contact

CBD OIL

Cannabis Control Commissioner Jennifer Flanagan Announces Departure from the Agency on April 30

April 13, 2021 by CBD OIL

When companies raise capital and grow, the No. 1 thing they do is hire.

Vangst, a Denver-based recruiting platform that connects cannabis job seekers with employers, is now better positioned to service that demand after launching its Executive Talent service March 29, with Jennifer Bedford as the vice president.

According to CEO Karson Humiston, who founded Vangst in 2015, more than 210,000 people are directly employed by the U.S. cannabis industry—a Leafly report estimated that number to be even higher, at 321,000—with a 75% growth in employment over the last two years. The new Executive Talent service will help companies secure administrative-level talent as they continue to build out and grow their leadership teams, she said.

“Before hiring [Bedford] at Vangst, we engaged her for our VP of revenue search. It was hands down the best experience I’ve ever had with an executive recruiter,” said Humiston, who turned around and reverse-recruited Bedford to join her team.

Before taking on the vice president of Executive Talent position at Vangst, Bedford was a veteran recruiter at Signal Partners, an executive search firm headquartered in Los Angeles, where she executed executive searches in the legal and compliant cannabis market. And before that, she serviced the consumer-facing tech sector. Overall, she is a 20-year veteran headhunter.

Vangst’s recruiting services include staffing cannabis companies with positions like marketing managers, budtenders and social media coordinators. But, until now, it did not have an executive talent offering—Bedford’s specialty.

“What CEO Karson Humiston has built is pretty much a top-tier staffing marketplace within cannabis, you know, a ZipRecruiter or an Indeed of the cannabis space,” Bedford said. “That’s exactly what we are building is a staffing recruiting talent marketplace within the most explosive growth consumer product sector in North America. It’s going to be super fun.

“We can elevate our game now for Vangst to be able to service the cannabis investors and to be able to service cannabis CEOs who want to build out their leadership teams that populate across the U.S.”

Here, Bedford shares more about how she became an executive recruiter in the cannabis space, tricks of the trade, how she connected with Humiston, where cannabis executives come from, how companies make their hires, how cannabis-sector recruitment stands out, what new states coming on board means for leadership teams and more.

Editor’s Note: This interview has been edited for style, length and clarity.

 

Tony Lange: How did you first get into your line of work?

Photo by Sarah Waters

Jennifer Bedford joins Vangst from Signal Partners. 

Jennifer Bedford: I cut my teeth at Korn/Ferry International—an executive search firm headquartered in Los Angeles—which is a really great place to learn the business. Executive search is not for the meek. There’s an art and a science to it. And I got to start with the best people in the business.

My Korn/Ferry days were all about technology. And what I learned the most from cutting my teeth was just knowing how to do this work. Getting top-level executives to get on the phone with you, there’s an art to that. So, I learned early on how to find whom I’m looking for and how to get them to talk to me.

TL: What are some of the tricks of the trade you learned early on in terms of executing leadership-level searches?

JB: The business that I’m in is a hybrid between sales and buying. I always say to people first I’m in sales because I’m trying to get “Tony” to talk to me. I like Tony’s background a lot. Tony looks like he’s a really good fit for that VP of marketing role that I have. I’m looking at Tony and I’m like, “Oh, I like him a lot.” So now I’ve got to get you to talk to me. I’m going to use my emails. If I can find any way to get you to talk to me, I’m going to do that. That’s what I learned at Korn/Ferry, is the relentlessness.

Then when I get to you, I’m going to give you the shortest amount of sell that I can so that you’ll talk to me. “My client is Apple.” Now Tony’s excited about listening to me because, boy, would he love to work for Apple. Once the sell part is accomplished, then I flip to being a buyer, which is now, “How good is Tony?” That is how executive search works. And what did I learn at Korn/Ferry? I learned how to do that.

TL: What else shaped your career path toward the cannabis sector?

JB: After Korn/Ferry, I pivoted into consumer technology, sort of grew up growing Silicon Valley technology companies, building out those leadership benches. And then I showed up at Signal Partners, my recent executive search firm that’s built to service investor-backed and owned operations here in Los Angeles—they’re a national leader as far as associating themselves with the investor side of the house. So, I was introduced to clients through the venture capital firm, or through the private equity firm, and that was Signal Partners’ sweet spot.

When cannabis clients started tapping on my shoulder and I started doing cannabis-related tech searches out of the gate, and started building cannabis technology companies and marketplaces, I went to my partners and said, “You guys, I should just call it our cannabis practice. Can I just put that stick in the sand and call it what it is?” And the answer was absolutely. We created a tech stack that was like a Porsche. To be really good in this business, you’ve got to have a killer tech stack, because if you hire me to do your chief marketing officer search, I want to know within 48 hours who are the best marketing leaders in that lane, and how can I go after them, and how can I find them. That’s what the back of the house looks like when I get an assignment like that.

TL: What year was that when you launched the cannabis practice at Signal Partners?

JB: I would say my phone started heating up with cannabis calls in late 2017, early 2018. And because my network is investors, I’ve spent years building my network of chief executives, executive-level operators, executives in supply chain and executives in technology. So, when those calls started, it was very easy for me to pivot. It was like just another consumer product lane. “Oh, I just did a kombucha search last year. Now I can do this hemp CBD beverage company, no problem.” [CBD is] the fastest growing consumer product category in the world. The same kind of executives want to get into it.

TL: Where are executives who want to join the cannabis space coming from?

JB: Well, the answers are pharma, supply chain, distribution—it’s consumer product boxed categories, technology, etc. So, my job is to sort through all of that talent and find the premier-level talent that is a trusted, vetted-out executive.

TL: Do leadership-level hires often have to relocate?

JB: That’s not a big thing right now with some states still shut down and a lot of people working remote. I don’t think you need to focus too much on that. Companies are making hires based on talent, which is, “Has she done this? Is she a rock star? How do we back-channel her?” I’ll use the edibles category, for example, “Oh, she took that jelly bean company from $650 million in revenue to $1.2 billion in revenue? Let’s talk to her.”

So, it’s much more than location. The concentration from our side of the desk is, what’s the talent? Then, as far as relocating, if you live in Brooklyn but I’m headquartered in Chicago, we don’t care right now. If it’s a job in which face-to-face is critical, then we’ll adapt.

TL: How did your previous experiences align you with your role as the vice president of the new Executive Talent service at Vangst?

JB: If I’ve spent the last 20 years building a prestigious network of killer executives, Vangst likewise has spent the last five years building the best staffing and recruiting brand name in the business. So, it was a really nice fit for me to go, “Oh, these are my people.” I can bring what I do to them.

TL: How did you connect with Vangst CEO Karson Humiston to conduct her vice president of revenue search (before she hired you as a full-time team member)?

JB: I had just finished LeafLink’s chief revenue officer search and recruited a guy out of a software-as-a-service marketplace company, and I had also found LeafLink’s head of insights, so I think LeafLink CEO Ryan Smith had suggested Humiston talk to me. That’s how the introduction was made.

TL: How does being a headhunter in the cannabis space differ from other arenas, and who are your competitors?

JB: Remember, I’m a talent scout at the executive level. Cannabis multistate operators right now want to grow and establish their executive teams. And that’s the sole focus right now is how do we have a big 2021? How do we do that? We do that by having killer executives—smart, social-equity focused, you know, cares about their organization, revenue-driven, all of that.

And so, my focus is on those multistate operators and on existing Vangst clients. We get to elevate Vangst’s clients’ game right now by giving them an executive search offering that they previously had to go out and use a search firm. You could say there’s competitors at the executive-search level with a few boutiques out there—like what I did at Signal Partners—that are doing our work. Those were my competitors then. And you’re starting to hear more search firms starting to put up their little cannabis flags and saying we can do that.

But I’m super proud to walk in the door at Vangst with a deep network of not only existing cannabis executives, but also a thousand executives with their hands in the air waiting to be called on. People want to get into this fast-growth sector.

TL: Companies are obviously counting on you to recommend the right person for the job so that they’re not coming back three months later starting from scratch—how do your executive talent searches ensure matches are a win-win for both employer and employee.

JB: You’re asking the age-old question about the part of the business that’s called human capital, and human capital is not for the meek. If you haven’t done your job right as a recruiter and you didn’t vet out what his or her weaknesses are, or vet out that his or her spouse didn’t want to be in that sector, or that his or her kid needed a special school and that relocating was a bad idea—in the human-capital space, you’ve got to know all that. You’ve got to do that homework and prepare as best as possible for this candidate to be successful at the company.

If somebody falls out at three months, what do we do? Well, there are different contractual promises that I say to a client. But my job is to give you a candidate who is so psyched to grow the business, and I’ve done all the homework to make sure that they’re not going to fall out.

TL: Virginia, New York and New Mexico are some of the recent states making moves to legalize adult-use cannabis. Do you feel more pressure to understand those additional state-legal markets, or are you more excited for additional opportunities?

JB: Great question; it’s both. The excitement level not only is elevating on a state-by-state basis, but also at the federal level. What cannabis has always been from the beginning has been a state-by-state chess game. And we’re all moving our chess pieces one piece at a time. And I think what we’re seeing in the state-by-state legalization conversation is that if you look at New York as an example, we’re getting better at this. As legalization efforts are hitting the East, the cannabis sector is so much more mature now. And if you fold the politics and the social equity components and the expungement components and all of that, really what I call good-news aspects of cannabis legalization, you’re going to see us getting better. You’re going to see this sector getting better. It really is analogous to other growth industries that we’ve seen over time.

And I pay attention to history. I pay attention to industries that have had their growing pains. And, boy, last year with the pandemic was certainly one of them for cannabis because cannabis, yes, we were deemed an essential medicine right at the beginning of COVID-19, but there was also a lot of recalibrating that went on last year. So, I think we’re hitting our stride. I think MSOs, Vangst clients, cannabis companies, cannabis ancillary companies, the technology companies associated with the sector, everybody is really flexing this year. It’s going to be a year in which you’re going to see a ton of growth. And, from my perspective, as somebody who cares about the sector, I want to see that growth from the executive level and from the C-suite. I want to see it done thoughtfully and carefully.

Filed Under: Cannabis News

Leaders in Cannabis Formulations: Part 2

April 13, 2021 by CBD OIL

Editor’s Note: In Part 1 of this series, green sat down with Drew Hathaway, senior food scientist at Stillwater Brands. Click here to see Part 1.


Natural cannabinoid distillates and isolates are hydrophobic oils and solids, meaning that they do not mix well with water and are poorly absorbed in the human body after consumption. By formulating these ingredients using a patented delivery system technology, trademarked VESIsorb®, Geocann has overcome common obstacles associated with fat-soluble active ingredients, including poor stability, bioavailability, absorption, and solubility. In addition, Geocann has peer-reviewed, published evidence of the dramatic improvements in Cmax, AUC, and Tmax (“time to peak absorption” directly related to “fast-acting” benefits).

Geocann is a cannabis formulation company with its headquarters in Fort Collins, Colorado, and additional offices in Chicago, Illinois and Zurich, Switzerland. The company is led by an impressive leadership team of scientists, pharmacists, researchers and natural product industry leaders. Geocann’s technology platform has been successfully applied to a wide range of cannabis product applications, including soft gel and hard-shell capsules, functional foods (e.g. gummies) and beverages, powder systems, tinctures, sublingual sprays and topically applied formulations. Brand partners in the U.S. utilizing Geocann’s technology for hemp applications include Nestlé Health Science, Cannaray and Onnit, and brand partners for medical and adult-use cannabis applications include Curaleaf, Sunderstorm and CannaCraft, among others.

We spoke with Jesse Lopez, CEO and Founder of Geocann, about their product formulation technology in cannabis and how they work with brand partners in the U.S and internationally. Lopez started Geocann in 2018 alongside the success he’s experienced at SourceOne Global Partners (founded in 2003 by Lopez), a leading formulation company in the nutraceuticals space with a reputation for pioneering innovative products that combine science-backed ingredients with patented drug delivery system technologies to address the most pressing consumer health concerns, such as heart health, cognitive function, inflammatory response, metabolic syndrome and type II diabetes, among others.

Aaron Green: Jesse, first off, how did you get involved in the cannabis industry?

Jesse Lopez: Our focus at SourceOne Global Partners has been on natural products for nearly two decades. Some of the folks involved with our natural products business decided that they would get involved in the cannabis business and they asked for my support at the Advisory Board level. I agreed to serve and figured I better learn about the cannabis industry! We realized that there was a tremendous opportunity for utilizing our drug delivery system technology to enhance the value of these cannabis-based products. Due to the regulatory environment, strategic legal counsel and new investments necessary to take an immediate leadership position in the cannabis industry we launched Geocann in 2018 with an office in a fully legal state at the time, Colorado.

Green: How do you select the natural products you work with at SourceOne?

Jesse Lopez, CEO and Founder of Geocann

Lopez: We really focus on science-backed natural product ingredients that may require high doses to reach therapeutic blood levels. By combining these science-backed ingredients with patented technologies – which we own the global rights to – these products offer desirable differentiation for leading brands, such as dramatically improved absorption and bioavailability, patent protection and trademarked “intel inside” branding.

Green: What are some of the other natural products you have experience with?

Lopez: We work with a range of some of the most popular nutraceuticals such as coenzyme Q10 and omega-3 fish oil to the more innovative natural products like resveratrol. We also work with vitamin D, and other immunity-based ingredients that can be enhanced using our delivery system technology to deliver greater benefits to the people that are taking those products.

Green: What is the technology and how does it work?

Lopez: I think it’s important to recognize our technology partner, Vesifact, in Zurich, Switzerland, who is the inventor of the VESIsorb® technology platform and serves as the scientific research, technical support, production, and product development arm of SourceOne and Geocann. We are very proud of this symbiotic relationship where our role at Geocann and SourceOne is to provide the commercial development, sales, marketing and strategic distribution infrastructure. We promote our partnership openly on our website and in our marketing materials because of their unrivaled leadership position in the global marketplace.

They have consistently been recognized as a top 10 global organization for health-related nanotechnology patent activity, ahead of many of the most well-known pharmaceutical companies in the world. It is an intellectual property portfolio that has been used to provide solutions to the most difficult product formulation challenges over the years in pharmaceuticals, medical devices, nutraceuticals, cosmetics, and now cannabis applications. Together, our focus has been on delivering novel solutions in these diverse fields of use and product applications based upon VESIsorb® formulation technology.

Each active compound identified with its own set of formulation, absorption and bioavailability challenges requires a customized solution that allows the full potential health benefits to be realized from success in the lab to commercial scale up. This is the process and we have successfully delivered unmatched solutions for close to twenty years from coenzyme Q10 to now both psychoactive and non-psychoactive cannabinoid product formulations in a wide range of product applications.

We saw the exploding interest in CBD with our nutraceutical partners and demanding consumers worldwide but chose to start Geocann to keep the markets served separate. We were confident that the VESIsorb® technology would provide much needed solutions for CBD as a wellness product, but also adult-use and medical cannabis products regarding “fast acting” and “product stability” needs.

Green: What’s the problem in cannabinoid bioavailability that Geocann’s technology helps to solve?

Lopez: It is well-recognized in the scientific literature that CBD, THC and other cannabinoids, in general, show limited bioavailability due to their lipophilicity, poor aqueous solubility and extensive first-pass metabolism.

Our VESIsorb® technology was designed to address the poor bioavailability of drugs and natural bioactives like cannabinoids exhibiting poor water solubility but high membrane permeability (Biopharmaceutical Classification System: Class II compounds). The VESIsorb® technology is a lipid-based formulation that self-assembles on contact with an aqueous phase into a colloidal delivery system. This colloidal solubilization improves the transport of the cannabinoids through the aqueous phase of the GI-lumen to the absorptive epithelium, dramatically improving bioavailability.

VESIsorb® is typically characterized as a SEDDS (self-emulsifying drug delivery system). What’s unique about our VESIsorb® SEDDS is the long history of safe and effective use worldwide and the large number of products that, over the years, we’ve successfully developed. With decades of experience delivering novel formulation solutions, there is significant and valuable “know how” that we bring to each formulation challenge.  This “know how” allows us, for example, to develop cannabinoid formulations that provide lymphatic absorption pathway advantages in addition to standard gastrointestinal absorption, therefore optimizing therapeutic blood levels for maximum benefits.

Needless to say, there are various methods that attempt to address the poor cannabinoid bioavailability. Unfortunately, too often, companies make claims that they have water soluble cannabinoids but offer little evidence to validate their claims. The popular misconception is that some degree of water solubility will consistently translate to improved bioavailability. This is clearly not accurate. We know scientifically that pharmacokinetic performance is highly variable. A review paper I read recently comparing water soluble delivery system formulation types illustrated this fact. There was greater than an eight-fold difference in bioavailability amongst the various water-soluble formulations.

Green: Can you tell me some details about your global license with Vesifact?

Lopez: Our technology exclusivity is based upon given categories. So, when we say we have global exclusivity for nutraceuticals, that can be as I’ve already mentioned, omega-3, coenzyme Q10, or resveratrol as examples, and this business is managed by SourceOne. With regards to our global exclusivity for cannabinoids and terpenes– whether we formulate these ingredients to create a functional drink, or we’re creating a gummy, or creating a softgel capsule or powder-filled hard-shell capsule, or sublingual, or topical – all of those product applications are covered by ourexclusivity for the technology and is managed by Geocann.

The beauty of our technology is that we’ve already achieved success with all of those product applications. That’s one of the big advantages of our technology versus some other approaches trying to address the challenges of cannabinoid bioavailability.

Green: What kind of validation and clinical studies have you done so far in the cannabinoid space?

Lopez: We were the first to have stability data with creating our formulation in a soft gel capsule with CBD. We recently submitted to the European market for novel food application. We invested hundreds of thousands of dollars in proprietary safety studies that are required to achieve novel food status in Europe and FDA GRAS in the U.S. We have proprietary stability data as well as proprietary toxicology data from multiple, self-funded clinical studies. Many companies that submit for the EU novel food application are only referencing the existing scientific literature about the pharmacokinetics of cannabinoids, whereas we have our own peer-reviewed, published study. In our study, we compared our VESIsorb®-CBD formulation to the industry standard MCT Oil-CBD formulation in a crossover design where we were able to demonstrate how we could dramatically improve the bioavailability of CBD.

Green: Can you talk about the benefits of your technology with regards to bioavailability and onset time?

Lopez: When you start talking about onset time we move into a broader discussion relative to cannabinoids. We’ve been very successful with marijuana, especially as it relates to THC, because of the dramatic improvement in time to Tmax, and how much faster we reach Tmax than a standard THC formula. Our formulation is generally four times faster compared to standard formulations.

When it comes to area under the curve and Cmax, we show improvements of four to six times a standard THC or CBD product. Further, when we start looking at the differences between other studies that have been published, we show an even greater improvement based upon study comparisons to what other people have done, even compared to products like GW Pharmaceuticals’ Sativex Oromucosal Spray.

Green: Can you address the SEDDS formulation and liver metabolism?

Lopez: We’ve dramatically overcome challenges with the first-pass effect. We have also formulated our products to address lymphatic absorption. So, we’re coming at it from a number of different angles.

We disagree with people who talk about water solubility as an end-all be-all solution. When you look at the range of published studies, whether it’s nanoparticles or liposomal systems or micro-emulsions, they all are water soluble systems, but yet the data shows there’s dramatic differences in the real efficacy of those approaches, and what the actual improvement in blood levels are. Ultimately, those blood levels represent the efficacious nature of the products whether we’re talking about CBD, or talking about THC.

Green: As a Colorado-based company you work with cannabis partners across the US. Can you tell me about your relationship with marijuana product formulators and brands and how you structure your licensing agreements across state boundaries?

Lopez: In a recent article about the leading fast acting gummies, the two companies they focused on were Sunderstorm with the Kanha Nano gummies and Curaleaf with their Select Fast Acting Nano gummies. Both of those companies use our VESIsorb® technology. We’re very proud of our relationship and the success they’re having as leaders in most dominant states with that particular product application.

Onset time has always been a challenge with gummies. And we’ve dramatically improved onset. Actually, we’ve shown statistically significant improvements for all measured pharmacokinetic parameters in a recent peer-reviewed published study.  We demonstrated much higher total absorption in maximum plasma concentration (Cmax), total exposure [area under the curve (AUC)]) and the time to reach the peak concentration (Tmax).

We say powered by VESIsorb® technology the product is faster, stronger, longer.

Green: How does the experience differ from a standard oil- or isolate-based formulation?

Lopez: The only way that I can answer that question is we’ve had 100% success with the companies we work with in their initial trials. When someone tells me that a group of employees are going to try the product and they’re heavy users of cannabis and they are smokers, I think, “wow, you know, gummies have to be really successfully formulated for someone like that to be pleased with the high.” Then they come back and say, “that’s the best that I’ve had in four years!” and they’re totally blown away. That’s completely different than a peer reviewed published study, but for sure, that’s the kind of feedback and anecdotal evidence that we get. I think that’s why that application is growing so much faster now because we’ve overcome this onset issue.

Green: Do you give exclusive rights on a state-by-state basis?

Lopez: We’re very selective about who we work with. Exclusivity is always part of the discussion. But at the same time, it’s really more about protecting the investment in the people that we partner with and not cannibalizing a given market. So, there are some exclusive relationships in the U.S. and internationally, like Heritage Cannabis and Pathway Health Corp in Canada, but for the most part, I would say simply, we were very selective about who we do business with and open to new partnerships.

Green: What kind of support do you provide to your licensing partners?

Lopez: We provide 100% formulation and technical support. We provide the SEDDS and then they use their own legal, licensed cannabis and their own equipment. Our system requires no special equipment or investment in changes to their process. So, not only do we provide formulation expertise, but our system is really easy to use both in a lab environment as well as producing large scale commercial productions.

Green: What geographies are you in currently with the cannabinoid formulations?

Lopez: We are global in scope. We’ve been very fortunate to have success not only in the US and Canada, but Europe, Brazil and Australia as well. Our level of participation will vary whether we’re talking about medical marijuana, adult-use or hemp extract and CBD.

Green: If somebody is interested in learning more about your product or potentially becoming a license partner, how would they how would they reach out to you to set that up?

Lopez: If they went to our website, www.geocann.com, it’s pretty easy to reach us and I am grateful that so many companies are doing that.

Green: Great, thanks Jesse that concludes the interview!

Filed Under: Cannabis News

UPDATE: New Mexico Legalizes Adult-Use Cannabis

April 12, 2021 by CBD OIL

When companies raise capital and grow, the No. 1 thing they do is hire.

Vangst, a Denver-based recruiting platform that connects cannabis job seekers with employers, is now better positioned to service that demand after launching its Executive Talent service March 29, with Jennifer Bedford as the vice president.

According to CEO Karson Humiston, who founded Vangst in 2015, more than 210,000 people are directly employed by the U.S. cannabis industry—a Leafly report estimated that number to be even higher, at 321,000—with a 75% growth in employment over the last two years. The new Executive Talent service will help companies secure administrative-level talent as they continue to build out and grow their leadership teams, she said.

“Before hiring [Bedford] at Vangst, we engaged her for our VP of revenue search. It was hands down the best experience I’ve ever had with an executive recruiter,” said Humiston, who turned around and reverse-recruited Bedford to join her team.

Before taking on the vice president of Executive Talent position at Vangst, Bedford was a veteran recruiter at Signal Partners, an executive search firm headquartered in Los Angeles, where she executed executive searches in the legal and compliant cannabis market. And before that, she serviced the consumer-facing tech sector. Overall, she is a 20-year veteran headhunter.

Vangst’s recruiting services include staffing cannabis companies with positions like marketing managers, budtenders and social media coordinators. But, until now, it did not have an executive talent offering—Bedford’s specialty.

“What CEO Karson Humiston has built is pretty much a top-tier staffing marketplace within cannabis, you know, a ZipRecruiter or an Indeed of the cannabis space,” Bedford said. “That’s exactly what we are building is a staffing recruiting talent marketplace within the most explosive growth consumer product sector in North America. It’s going to be super fun.

“We can elevate our game now for Vangst to be able to service the cannabis investors and to be able to service cannabis CEOs who want to build out their leadership teams that populate across the U.S.”

Here, Bedford shares more about how she became an executive recruiter in the cannabis space, tricks of the trade, how she connected with Humiston, where cannabis executives come from, how companies make their hires, how cannabis-sector recruitment stands out, what new states coming on board means for leadership teams and more.

Editor’s Note: This interview has been edited for style, length and clarity.

 

Tony Lange: How did you first get into your line of work?

Photo by Sarah Waters

Jennifer Bedford joins Vangst from Signal Partners. 

Jennifer Bedford: I cut my teeth at Korn/Ferry International—an executive search firm headquartered in Los Angeles—which is a really great place to learn the business. Executive search is not for the meek. There’s an art and a science to it. And I got to start with the best people in the business.

My Korn/Ferry days were all about technology. And what I learned the most from cutting my teeth was just knowing how to do this work. Getting top-level executives to get on the phone with you, there’s an art to that. So, I learned early on how to find whom I’m looking for and how to get them to talk to me.

TL: What are some of the tricks of the trade you learned early on in terms of executing leadership-level searches?

JB: The business that I’m in is a hybrid between sales and buying. I always say to people first I’m in sales because I’m trying to get “Tony” to talk to me. I like Tony’s background a lot. Tony looks like he’s a really good fit for that VP of marketing role that I have. I’m looking at Tony and I’m like, “Oh, I like him a lot.” So now I’ve got to get you to talk to me. I’m going to use my emails. If I can find any way to get you to talk to me, I’m going to do that. That’s what I learned at Korn/Ferry, is the relentlessness.

Then when I get to you, I’m going to give you the shortest amount of sell that I can so that you’ll talk to me. “My client is Apple.” Now Tony’s excited about listening to me because, boy, would he love to work for Apple. Once the sell part is accomplished, then I flip to being a buyer, which is now, “How good is Tony?” That is how executive search works. And what did I learn at Korn/Ferry? I learned how to do that.

TL: What else shaped your career path toward the cannabis sector?

JB: After Korn/Ferry, I pivoted into consumer technology, sort of grew up growing Silicon Valley technology companies, building out those leadership benches. And then I showed up at Signal Partners, my recent executive search firm that’s built to service investor-backed and owned operations here in Los Angeles—they’re a national leader as far as associating themselves with the investor side of the house. So, I was introduced to clients through the venture capital firm, or through the private equity firm, and that was Signal Partners’ sweet spot.

When cannabis clients started tapping on my shoulder and I started doing cannabis-related tech searches out of the gate, and started building cannabis technology companies and marketplaces, I went to my partners and said, “You guys, I should just call it our cannabis practice. Can I just put that stick in the sand and call it what it is?” And the answer was absolutely. We created a tech stack that was like a Porsche. To be really good in this business, you’ve got to have a killer tech stack, because if you hire me to do your chief marketing officer search, I want to know within 48 hours who are the best marketing leaders in that lane, and how can I go after them, and how can I find them. That’s what the back of the house looks like when I get an assignment like that.

TL: What year was that when you launched the cannabis practice at Signal Partners?

JB: I would say my phone started heating up with cannabis calls in late 2017, early 2018. And because my network is investors, I’ve spent years building my network of chief executives, executive-level operators, executives in supply chain and executives in technology. So, when those calls started, it was very easy for me to pivot. It was like just another consumer product lane. “Oh, I just did a kombucha search last year. Now I can do this hemp CBD beverage company, no problem.” [CBD is] the fastest growing consumer product category in the world. The same kind of executives want to get into it.

TL: Where are executives who want to join the cannabis space coming from?

JB: Well, the answers are pharma, supply chain, distribution—it’s consumer product boxed categories, technology, etc. So, my job is to sort through all of that talent and find the premier-level talent that is a trusted, vetted-out executive.

TL: Do leadership-level hires often have to relocate?

JB: That’s not a big thing right now with some states still shut down and a lot of people working remote. I don’t think you need to focus too much on that. Companies are making hires based on talent, which is, “Has she done this? Is she a rock star? How do we back-channel her?” I’ll use the edibles category, for example, “Oh, she took that jelly bean company from $650 million in revenue to $1.2 billion in revenue? Let’s talk to her.”

So, it’s much more than location. The concentration from our side of the desk is, what’s the talent? Then, as far as relocating, if you live in Brooklyn but I’m headquartered in Chicago, we don’t care right now. If it’s a job in which face-to-face is critical, then we’ll adapt.

TL: How did your previous experiences align you with your role as the vice president of the new Executive Talent service at Vangst?

JB: If I’ve spent the last 20 years building a prestigious network of killer executives, Vangst likewise has spent the last five years building the best staffing and recruiting brand name in the business. So, it was a really nice fit for me to go, “Oh, these are my people.” I can bring what I do to them.

TL: How did you connect with Vangst CEO Karson Humiston to conduct her vice president of revenue search (before she hired you as a full-time team member)?

JB: I had just finished LeafLink’s chief revenue officer search and recruited a guy out of a software-as-a-service marketplace company, and I had also found LeafLink’s head of insights, so I think LeafLink CEO Ryan Smith had suggested Humiston talk to me. That’s how the introduction was made.

TL: How does being a headhunter in the cannabis space differ from other arenas, and who are your competitors?

JB: Remember, I’m a talent scout at the executive level. Cannabis multistate operators right now want to grow and establish their executive teams. And that’s the sole focus right now is how do we have a big 2021? How do we do that? We do that by having killer executives—smart, social-equity focused, you know, cares about their organization, revenue-driven, all of that.

And so, my focus is on those multistate operators and on existing Vangst clients. We get to elevate Vangst’s clients’ game right now by giving them an executive search offering that they previously had to go out and use a search firm. You could say there’s competitors at the executive-search level with a few boutiques out there—like what I did at Signal Partners—that are doing our work. Those were my competitors then. And you’re starting to hear more search firms starting to put up their little cannabis flags and saying we can do that.

But I’m super proud to walk in the door at Vangst with a deep network of not only existing cannabis executives, but also a thousand executives with their hands in the air waiting to be called on. People want to get into this fast-growth sector.

TL: Companies are obviously counting on you to recommend the right person for the job so that they’re not coming back three months later starting from scratch—how do your executive talent searches ensure matches are a win-win for both employer and employee.

JB: You’re asking the age-old question about the part of the business that’s called human capital, and human capital is not for the meek. If you haven’t done your job right as a recruiter and you didn’t vet out what his or her weaknesses are, or vet out that his or her spouse didn’t want to be in that sector, or that his or her kid needed a special school and that relocating was a bad idea—in the human-capital space, you’ve got to know all that. You’ve got to do that homework and prepare as best as possible for this candidate to be successful at the company.

If somebody falls out at three months, what do we do? Well, there are different contractual promises that I say to a client. But my job is to give you a candidate who is so psyched to grow the business, and I’ve done all the homework to make sure that they’re not going to fall out.

TL: Virginia, New York and New Mexico are some of the recent states making moves to legalize adult-use cannabis. Do you feel more pressure to understand those additional state-legal markets, or are you more excited for additional opportunities?

JB: Great question; it’s both. The excitement level not only is elevating on a state-by-state basis, but also at the federal level. What cannabis has always been from the beginning has been a state-by-state chess game. And we’re all moving our chess pieces one piece at a time. And I think what we’re seeing in the state-by-state legalization conversation is that if you look at New York as an example, we’re getting better at this. As legalization efforts are hitting the East, the cannabis sector is so much more mature now. And if you fold the politics and the social equity components and the expungement components and all of that, really what I call good-news aspects of cannabis legalization, you’re going to see us getting better. You’re going to see this sector getting better. It really is analogous to other growth industries that we’ve seen over time.

And I pay attention to history. I pay attention to industries that have had their growing pains. And, boy, last year with the pandemic was certainly one of them for cannabis because cannabis, yes, we were deemed an essential medicine right at the beginning of COVID-19, but there was also a lot of recalibrating that went on last year. So, I think we’re hitting our stride. I think MSOs, Vangst clients, cannabis companies, cannabis ancillary companies, the technology companies associated with the sector, everybody is really flexing this year. It’s going to be a year in which you’re going to see a ton of growth. And, from my perspective, as somebody who cares about the sector, I want to see that growth from the executive level and from the C-suite. I want to see it done thoughtfully and carefully.

Filed Under: Cannabis News

Be conservative with CBD claims or risk receiving a warning letter from the FDA

April 12, 2021 by CBD OIL

Cannabidiol (CBD) is so popular that it can practically sell itself. Still, any establishment selling CBD still needs a comprehensive strategy to promote their products that is not only effective but also within the law. Since the 2018 bill legalizing hemp and its derivatives, including CBD, many companies have had problems with and received legal issues related to the promotion of their products Warning letters from the Food and Drug Administration (FDA). Fortunately, there are ways for companies to ensure that their marketing activities stay within the laws and regulations set by the FDA.

A large number of letters The information released in recent years has been sent to companies making illegal claims that their CBD products can be used to “prevent, diagnose, alleviate, treat or cure various diseases.” This directly violates the Federal Food, Drugs, and Cosmetics Act (FD&C Act). If a company wants to assert such claimstheir product must be “FDA approved or conform to a” monograph “for a specific drug category as determined by the FDA’s over-the-counter drug review before they can be legally marketed as a drug”. And CBD is not verified by OTC. A company can also receive a warning letter if it sells an unapproved OTC drug that has CBD listed as an inactive ingredient.

This ban on advertising CBD as a medicinal product applies not only to products intended for human consumption, but also to products intended for animal consumption. In addition, there is CBD not confirmed as a food additive still approved as a food supplement.

When a company receives a warning letter, it has 15 working days Responding to the FDA to prove that the legal issue was addressed or to respond with an argument about why their product is not in violation of the law.

The FDA is closely monitoring CBD products and is currently developing comprehensive regulations and guidelines for their manufacture, marketing, and sale. CBD companies need to follow FDA developments closely to stay on the right side of the law. As such, companies should hire legal counsel to ensure their actions are fully in line with the FDA. This saves time, money, and effort, and helps ensure these companies have a bright future in the evolving CBD market.

Credit: comment

Image source: https://pixabay.com/photos/sign-stop-warning-stop-sign-symbol-1732791/

Filed Under: CBD Health

CBD versus CBN

April 12, 2021 by CBD OIL

Judging by their names, cannabidiol (CBD) and cannabinol (CBN) may seem like first cousins, but this is simply wrong, as their origins and their mode of action are fundamentally different. Nevertheless, they have some things in common and can even complement each other.

For starters, CBN is the result of THC oxidation. When tetrahydrocannabinol (THC) is exposed to heat, light, and / or time, it converts to CBN. This makes CBN a very sparse cannabinoid. Conversely, CBD is the second most important cannabinoid, although it also comes from a different molecule.

That sounds a little bit humiliating towards CBN, and while it is literally “degraded” THC, it has some nice perks too.

Like CBD, CBN is non-intoxicating. That being said, it is ultimately the by-product of THC and as such binds to cannabinoid 1 (CB)1) Receptor, even if only at about 10% of the THC affinity.[1] For this reason, the anecdotal evidence that the effects of CBN can border on mild poisoning seems plausible.

Considering that like THC, the apple doesn’t fall far from the tree, it was also found in preclinical research that CBN increased appetite while CBD actually decreased food consumption.[2] The feeding effects of CBN, if backed by further study, could be a great alternative to using THC for people facing loss of appetite.

On the other hand, it is believed that CBD negates or offsets the psychoactive effects of THC and in particular side effects such as paranoia.[3]

However, CBN and CBD have been studied together in the context of pain relief in preclinical models. Both cannabinoids were found to relieve myofascial pain, and combination treatment increased the effects.[1] These results indicate that despite their different properties, these two compounds may work better together in some conditions such as chronic pain.

In addition, like CBD, CBN can have anti-inflammatory and antispasmodic properties.[4] While many people claim that CBN could help with sleep, there is no data to effectively back it up.

As you can see, CBN and CBD are very different, but share some similarities. This is a recurring theme in cannabis science as a whole that may be at the core of the entourage effect and the unique relationship that cannabinoids share like a group of best friends united and completed by their differences.

New information about the little cannabinoids doesn’t let the CBD benefits out of the window! Instead, it offers options to try these new isolate compounds or use them in combination with CBD to see what they can do together.

Credit: Alex Green

Image source: https://www.pexels.com/photo/couple-wearing-couple-outfit-6626094/

References:

  1. Wong H & Cairns BE. Cannabidiol, cannabinol, and their combinations act as peripheral analgesics in a rat model of myofascial pain. Arch Oral Biol. 2019; 104: 33- 39.
  2. Farrimond JA et al. Cannabinol and cannabidiol have opposite effects on the feeding pattern of rats. Psychopharmacology (Berl). 2012; 223 (1): 117-1. 129.
  3. Niesink RJ & van Laar MW. Does cannabidiol protect against the adverse psychological effects of THC? Frontal psychiatry. 2013; 4: 130.
  4. Russo EB. Taming THC: Potential Cannabis Synergy and Phytocannabinoid Terpenoid Entourage Effects. Br J Pharmacol. 2011; 163 (7): 1344-13. 1364.

The post CBD versus CBN first appeared on CBD health and wellness.

Filed Under: CBD Health

Executive Leadership Teams Ready to Build Out in 2021: Q&A With Vangst Vice President of Executive Talent Jennifer Bedford

April 12, 2021 by CBD OIL

When companies raise capital and grow, the No. 1 thing they do is hire.

Vangst, a Denver-based recruiting platform that connects cannabis job seekers with employers, is now better positioned to service that demand after launching its Executive Talent service March 29, with Jennifer Bedford as the vice president.

According to CEO Karson Humiston, who founded Vangst in 2015, more than 210,000 people are directly employed by the U.S. cannabis industry—a Leafly report estimated that number to be even higher, at 321,000—with a 75% growth in employment over the last two years. The new Executive Talent service will help companies secure administrative-level talent as they continue to build out and grow their leadership teams, she said.

“Before hiring [Bedford] at Vangst, we engaged her for our VP of revenue search. It was hands down the best experience I’ve ever had with an executive recruiter,” said Humiston, who turned around and reverse-recruited Bedford to join her team.

Before taking on the vice president of Executive Talent position at Vangst, Bedford was a veteran recruiter at Signal Partners, a management consulting firm headquartered in Los Angeles, where she executed executive searches in the legal and compliant cannabis market. And before that, she serviced the consumer-facing tech sector. Overall, she is a 20-year veteran headhunter.

Vangst’s recruiting services include staffing cannabis companies with positions like marketing managers, budtenders and social media coordinators. But, until now, it did not have an executive talent offering—Bedford’s specialty.

“What CEO Karson Humiston has built is pretty much a top-tier staffing marketplace within cannabis, you know, a ZipRecruiter or an Indeed of the cannabis space,” Bedford said. “That’s exactly what we are building is a staffing recruiting talent marketplace within the most explosive growth consumer product sector in North America. It’s going to be super fun.

“We can elevate our game now for Vangst to be able to service cannabis investors and to be able to service cannabis CEOs who want to build out their leadership teams that populate across the U.S.”

Here, Bedford shares more about how she became an executive recruiter in the cannabis space, tricks of the trade, how she connected with Humiston, where cannabis executives come from, how companies make their hires, how cannabis-sector recruitment stands out, what new states coming on board means for leadership teams and more.

Editor’s Note: This interview has been edited for style, length and clarity.

 

Tony Lange: How did you first get into your line of work?

Photo by Sarah Waters

Jennifer Bedford joins Vangst from Signal Partners. 

Jennifer Bedford: I cut my teeth at Korn Ferry International—a management consulting firm, with an executive search service headquartered in Los Angeles—which is a really great place to learn the business. Executive search is not for the meek. There’s an art and a science to it. And I got to start with the best people in the business.

My Korn Ferry days were all about technology. And what I learned the most from cutting my teeth was just knowing how to do this work. Getting top-level executives to get on the phone with you, there’s an art to that. So, I learned early on how to find whom I’m looking for and how to get them to talk to me.

TL: What are some of the tricks of the trade you learned early on in terms of executing leadership-level searches?

JB: The business that I’m in is a hybrid between sales and buying. I always say to people first I’m in sales because I’m trying to get “Tony” to talk to me. I like Tony’s background a lot. Tony looks like he’s a really good fit for that VP of marketing role that I have. I’m looking at Tony and I’m like, “Oh, I like him a lot.” So now I’ve got to get you to talk to me. I’m going to use my emails. If I can find any way to get you to talk to me, I’m going to do that. That’s what I learned at Korn Ferry, is the relentlessness.

Then when I get to you, I’m going to give you the shortest amount of sell that I can so that you’ll talk to me. “My client is Apple.” Now Tony’s excited about listening to me because, boy, would he love to work for Apple. Once the sell part is accomplished, then I flip to being a buyer, which is now, “How good is Tony?” That is how executive search works. And what did I learn at Korn Ferry? I learned how to do that.

TL: What else shaped your career path toward the cannabis sector?

JB: After Korn Ferry, I pivoted into consumer technology, sort of grew up growing Silicon Valley technology companies, building out those leadership benches. And then I showed up at Signal Partners, my recent executive search firm that’s built to service investor-backed and owned operations here in Los Angeles—they’re a national leader as far as associating themselves with the investor side of the house. So, I was introduced to clients through the venture capital firm, or through the private equity firm, and that was Signal Partners’ sweet spot.

When cannabis clients started tapping on my shoulder and I started doing cannabis-related tech searches out of the gate, and started building cannabis technology companies and marketplaces, I went to my partners and said, “You guys, I should just call it our cannabis practice. Can I just put that stick in the sand and call it what it is?” And the answer was absolutely. We created a tech stack that was like a Porsche. To be really good in this business, you’ve got to have a killer tech stack, because if you hire me to do your chief marketing officer search, I want to know within 48 hours who are the best marketing leaders in that lane, and how can I go after them, and how can I find them. That’s what the back of the house looks like when I get an assignment like that.

TL: What year was that when you launched the cannabis practice at Signal Partners?

JB: I would say my phone started heating up with cannabis calls in late 2017, early 2018. And because my network is investors, I’ve spent years building my network of chief executives, executive-level operators, executives in supply chain and executives in technology. So, when those calls started, it was very easy for me to pivot. It was like just another consumer product lane. “Oh, I just did a kombucha search last year. Now I can do this hemp CBD beverage company, no problem.” [CBD is] the fastest growing consumer product category in the world. The same kind of executives want to get into it.

TL: Where are executives who want to join the cannabis space coming from?

JB: Well, the answers are pharma, supply chain, distribution—it’s consumer product boxed categories, technology, etc. So, my job is to sort through all of that talent and find the premier-level talent that is a trusted, vetted-out executive.

TL: Do leadership-level hires often have to relocate?

JB: That’s not a big thing right now with some states still shut down and a lot of people working remote. I don’t think you need to focus too much on that. Companies are making hires based on talent, which is, “Has she done this? Is she a rock star? How do we back-channel her?” I’ll use the edibles category, for example, “Oh, she took that jelly bean company from $650 million in revenue to $1.2 billion in revenue? Let’s talk to her.”

So, it’s much more than location. The concentration from our side of the desk is, what’s the talent? Then, as far as relocating, if you live in Brooklyn but I’m headquartered in Chicago, we don’t care right now. If it’s a job in which face-to-face is critical, then we’ll adapt.

TL: How did your previous experiences align you with your role as the vice president of the new Executive Talent service at Vangst?

JB: If I’ve spent the last 20 years building a prestigious network of killer executives, Vangst likewise has spent the last five years building the best staffing and recruiting brand name in the business. So, it was a really nice fit for me to go, “Oh, these are my people.” I can bring what I do to them.

TL: How did you connect with Vangst CEO Karson Humiston to conduct her vice president of revenue search (before she hired you as a full-time team member)?

JB: I had just finished LeafLink’s chief revenue officer search and recruited a guy out of a Statistical Analysis System (SAS) software marketplace company, and I had also found LeafLink’s head of insights, so I think LeafLink CEO Ryan Smith had suggested Humiston talk to me. That’s how the introduction was made.

TL: How does being a headhunter in the cannabis space differ from other arenas, and who are your competitors?

JB: Remember, I’m a talent scout at the executive level. Cannabis multistate operators right now want to grow and establish their executive teams. And that’s the sole focus right now is how do we have a big 2021? How do we do that? We do that by having killer executives—smart, social-equity focused, you know, cares about their organization, revenue-driven, all of that.

And so, my focus is on those multistate operators and on existing Vangst clients. We get to elevate Vangst’s clients’ game right now by giving them an executive search offering that they previously had to go out and use a search firm. You could say there’s competitors at the executive-search level with a few boutiques out there—like what I did at Signal Partners—that are doing our work. Those were my competitors then. And you’re starting to hear more search firms starting to put up their little cannabis flags and saying we can do that.

But I’m super proud to walk in the door at Vangst with a deep network of not only existing cannabis executives, but also a thousand executives with their hands in the air waiting to be called on. People want to get into this fast-growth sector.

TL: Companies are obviously counting on you to recommend the right person for the job so that they’re not coming back three months later starting from scratch—how do your executive talent searches ensure matches are a win-win for both employer and employee.

JB: You’re asking the age-old question about the part of the business that’s called human capital, and human capital is not for the meek. If you haven’t done your job right as a recruiter and you didn’t vet out what his or her weaknesses are, or vet out that his or her spouse didn’t want to be in that sector, or that his or her kid needed a special school and that relocating was a bad idea—in the human-capital space, you’ve got to know all that. You’ve got to do that homework and prepare as best as possible for this candidate to be successful at the company.

If somebody falls out at three months, what do we do? Well, there are different contractual promises that I say to a client. But my job is to give you a candidate who is so psyched to grow the business, and I’ve done all the homework to make sure that they’re not going to fall out.

TL: Virginia, New York and New Mexico are some of the recent states making moves to legalize adult-use cannabis. Do you feel more pressure to understand those additional state-legal markets, or are you more excited for additional opportunities?

JB: Great question; it’s both. The excitement level not only is elevating on a state-by-state basis, but also at the federal level. What cannabis has always been from the beginning has been a state-by-state chess game. And we’re all moving our chess pieces one piece at a time. And I think what we’re seeing in the state-by-state legalization conversation is that if you look at New York as an example, we’re getting better at this. As legalization efforts are hitting the East, the cannabis sector is so much more mature now. And if you fold the politics and the social equity components and the expungement components and all of that, really what I call good-news aspects of cannabis legalization, you’re going to see us getting better. You’re going to see this sector getting better. It really is analogous to other growth industries that we’ve seen over time.

And I pay attention to history. I pay attention to industries that have had their growing pains. And, boy, last year with the pandemic was certainly one of them for cannabis because cannabis, yes, we were deemed an essential medicine right at the beginning of COVID-19, but there was also a lot of recalibrating that went on last year. So, I think we’re hitting our stride. I think MSOs, Vangst clients, cannabis companies, cannabis ancillary companies, the technology companies associated with the sector, everybody is really flexing this year. It’s going to be a year in which you’re going to see a ton of growth. And, from my perspective, as somebody who cares about the sector, I want to see that growth from the executive level and from the C-suite. I want to see it done thoughtfully and carefully

Filed Under: Cannabis News

Five Things Every Cannabis Business Needs Before They Open

April 12, 2021 by CBD OIL

When it comes to small business opportunities these days, few phrases give people the old dollar-sign-eyes more than “legal cannabis”.

From states like Michigan where it’s been approved for both medicinal and adult use, to places like South Carolina where legalization has been a popular topic for ballots and voters, cannabis is slowly turning into one of America’s biggest businesses.

You don’t need us to tell you that – Investopedia reports that (as of Nov. 2020) over 340,000 American jobs were devoted to the handling of plants at various stages along the retail cycle, and the industry was estimated at over $13 billion as of 2019.

Not bad for a plant that’s still technically illegal under federal law, huh?

If you’ve read this far, it probably means you’re hoping to be among the lucky ones who can strike it rich with their own cannabis business. A noble undertaking, but are you really prepared to make your mark? In a field as competitive – and occasionally complicated – as cannabis can be, you really need to lead with your best foot forward, and make sure you’re as well prepared for the various challenges of a fairly new industry as possible.

With that in mind, below is a list of the five things you’ll need to double-check and make sure you actually have access to before embarking on your new business venture.

The right shelving & equipment

You see this a lot with smaller businesses as well as, er, ‘independent growers’. A lot of people assume that they can just buy some greenhouse shelves, line the walls of their business with it, and call it a day, right?

Offering rare or unique cannabis strains is a great way to differentiate

This approach leads to problems more often than not. Even above and beyond the inherent concerns of helping your plants grow safely (and productively!), the sort of equipment you use should reflect the sort of business you’re trying to run. A cannabis retail outlet, for example, is going to need different sorts of shelves and tables than a dispensary or growing facility, as the work being done is completely different.

It will take a little research, but it helps that a lot of businesses these days are starting to offer shelving specifically designed for various cannabis operations. Check to see if any of the big warehouse suppliers near you have gotten into the cannabis game yet – Shelving Inc, Metro, and Rack & Shelf are a few of the bigger shelving names with cannabis offerings as of this writing.

Strong branding

Long gone are the days when all you needed to be successful in cannabis was a booth at the shady flea market, a pun name and a big sign that said “Head Shop” to throw off the authorities.

Far too many cannabis businesses launch themselves headlong into a business plan without stopping to think of a good name, or just settling for the first one they think of. With as crowded as the playing field is quickly becoming, it might honestly be worth it to pay someone to help you come up with a decent logo and branding – it’ll go a long way towards helping you stand out against everyone else using a green font. Places online like High Hopes specifically offer these services for cannabis businesses, so you know they’ll be able to figure out what you’re about more quickly.

An understanding of your consumer base

The exact sort of work your cannabis business performs is going to affect what your potential customer base can be – and vice versa.

Brands are embracing contemporary design more and more

Early on in the planning stages, make sure to figure out exactly who you’re going to sell your products to, as this will inform nearly every other decision your business makes. Do you want to sell directly to the customer, or to work as a distributor for CBD/cannabis retail outlets? Are you prepared to manage and run your own storefront, or are you just going to rent warehousing space to sell your plants to other retailers? If so, do you know who the businesses are in your area that you could work with? Or, if you are planning on entering the retail space, do you know how many other cannabis businesses could be operating in your desired geographical area? Finding an audience may be the hardest part of opening any business, but it’s important work.

Banking that understands your industry

Maybe the biggest drawback to being involved in an industry as comparatively new as cannabis, is that a lot of the old methods of doing business aren’t quite available to you. Many financial institutions of various sizes are limited in the ways they can help finance cannabis businesses, from not understanding the regulations and needs of your industry, all the way to being unable to assist cannabis businesses with banking in the first place.

Finding the right banking services can be challenging

It might be advantageous to look into banks, credit unions or financing companies in your area that specifically offer banking services (like business accounts and the like). A few examples include Aery Group from New Mexico, or Seed to Sale in Michigan. (It’s important to note that many of these companies, such as Aery Group, can only service the state they’re located in due to different state-by-state regulations – check ahead to make sure you find a place that can help you!)

Knowledge of the needed licensing and regulatory requirements

Getting a license to open any business is a tricky prospect on a good day, but for an industry as wide-ranging and varied as cannabis, getting licensed can require a lot of homework.

Even if you’re lucky enough to be setting up shop in a state that allows for the sale of cannabis, the licensing process can vary widely from state-to-state. In New Mexico, for example, it can take months to acquire a license simply due to the amount of paperwork, research and submissions required to cement your business. Before going too far down the rabbit hole of opening your business, make sure to take the time you need to completely research and understand the various local and state regulations you’ll need to adhere to for your business to get off the ground.

Obviously, there’s going to be a lot of other hurdles and requirements that come with starting a business – but by remembering these five things, you’ll be off to a much better start than many others.

Filed Under: Cannabis News

Montana Prepares Its Adult-Use Cannabis Market: Week in Review

April 10, 2021 by CBD OIL

Connecticut Gov. Ned Lamont’s adult-use cannabis bill is far from the finish line, but the criminal justice aspect of the legislation was vetted and approved by the Joint Judiciary Committee in a 22-16 vote April 6.

The proposed legislation, An Act Responsibly and Equitably Regulating Adult-Use Cannabis, which Lamont unveiled during his budget address Feb. 10, would authorize the automated erasure of criminal records for those with cannabis-related drug possession convictions and charges.

The overall bill remains a work in progress—with language involving financial issues, regulatory issues, licensing issues and more— but the Judiciary Committee’s due diligence was to get the criminal justice components of the bill right, said Rep. Steven Stafstrom (D), who co-chairs the committee and also co-sponsors the legislation, Senate Bill 888.

“Our cognizance really is on the criminal justice, erasure piece, and I certainly have not heard much opposition to that because I think the language we have in here is language we’ve vetted through fairly well on the criminal justice aspects,” he said during the committee’s meeting on Tuesday.

“On the criminal justice components of this bill, this bill retains and improves upon the language we’ve seen for the last couple years on erasure of prior cannabis convictions,” Stafstrom said. “It puts in place what I believe to be an appropriate mechanism to deal with the issue of driving under the influence, something that is I know of particular interest to this committee, particularly given the fact that neighboring states are undertaking legalization.”

Included in S.B. 888, law enforcement units would be required to have a minimum number of officers report to the Police Officer Standards and Training Council no later than Jan. 1, 2022, so that each unit has state-accredited drug recognition experts to ensure adequate availability of drug recognition experts can respond to instances of impaired driving. Law enforcement units would be able to call upon drug recognition experts from other law enforcement units as necessary and available.

To execute on that front, the Police Officer Standards and Training Council would work with the Highway Safety Office within the Department of Transportation to issue a joint plan to increase access to advanced roadside impaired driving enforcement training and drug recognition expert training for police officers and law enforcement units throughout the state, according to the bill.

Roadside safety and what constitutes probable cause during traffic stops without roadside tests available for cannabis, such as a breathalyzer test for alcohol, has been a reservation of legalizing adult-use cannabis among lawmakers in other states. Last week, roadside safety was part of the debate on the House floor of the New York Legislature.

“As we move through our legislative process, we are not oblivious to what is happening around us, and certainly just last week, New York put in a legalization and regulatory framework,” Stafstrom said. “Massachusetts, to our north, certainly has had legalized cannabis for several years. I think what we are trying to do as we maneuver through this process is to align our legalization effort in as many respects as we can with our neighboring states. And, so, we continue to study what has worked and what has not worked in other locations.”

During the Judiciary Committee meeting, Stafstrom highlighted several amendment’s to S.B. 888 that he said were made to address concerns the committee members heard during a public hearing on the bill.

According to Stafstrom, the Judiciary Committee’s revised bill:

  • Adds legislative appointments to the Social Equity Council and gives it additional authority as a permanent body to develop the means to ensure potential societal, equitable applicants have access to licenses, and that individuals from disproportionately impacted communities can get jobs in the industry.
  • Includes definitive language to clarify that from July 1, 2021 through Jan. 1, 2024, only the existing medical establishments and social equity applicants can open cannabis establishments; and that cannabis establishments have a social equity plan and agree to labor peace and prevailing wage provisions.
  • Creates an accelerator program to provide technical support, mentoring, networking and apprenticeship opportunities for social equity applicants; and creates a workforce pipeline program to help individuals from impacted communities get jobs in the industry.
  • Allows patients in the medical program to home grow up to six plants starting May 1, 2022.
  • Provides the framework for issues involving local zoning and local control of allowing cannabis establishments in individual municipalities.
  • Provides additional employer protections, particularly for federal defense contractors.
  • Proposes that the revenue generated from the sale of cannabis be spent 55% on social equity efforts, 15% to grants for prevention and recovery services and 30% to the general fund to cover administrative costs.

“Those are proposals coming out of this committee based on the concerns and the testimony we heard at the public hearing, but certainly this is not the end of the conversation of the bill before us,” Stafstrom said. “I’m sure we’ll see additional revision as it moves through the legislative process and its next committee of assignment.”

Sen. Gary Winfield (D), who co-chairs the Joint Judiciary Committee, said S.B. 888 is a piece of legislation that he knew from the beginning was going to have a lot of effort put into it, and that he hopes the adult-use conversation continues so that the interests of all involved are represented.

“We also kind of knew that when we got to this point [the bill] wouldn’t be completely baked but that the conversation will continue after this point,” Winfield said. “There are people, both in the legislature and outside the legislature, who paid a lot of attention to this and have a lot of interest in the subject and have things that they want to see in this bill.”

All 22 yay votes out of the committee were from Democrats, while the 16 nays included 13 Republicans and three Democrats.

Rep. Craig Fishbein (R), a ranking member of the committee, said he could not support S.B. 888, or any cannabis legalization bill for that matter, until cannabis is federally legalized.

“Unfortunately, at the very outset, I, in respect for the oath that I took as a state representative to uphold the federal and state constitution, cannot find myself to be in support of this,” he said. “The fact of the matter is, we come together as the United States. And the federal constitution says that under the Supremacy Clause, if the federal government passes a law that state can’t invalidate it.”

Article VI, paragraph two of the U.S. Constitution is commonly referred to as the Supremacy Clause. It establishes that the federal constitution, and federal law, generally take precedence over state laws, and even state constitutions, according to Cornell Law School.

“State can’t say, ‘We don’t like that particular federal law,’ and do their own thing,” Fishbein said. “Through our representative government, we send representatives to Washington to represent our interests, and if residents of our state feel that this is a proper overture, then our representatives, our senators, our congresspeople advocate for a change in the federal law.”

While cannabis is not federally legal, the U.S. Department of Justice has not extended its reach to prosecute state-legal cannabis businesses in a fashion that has deterred lawmakers in 18 states and the District of Columbia from passing adult-use legalization measures. And before the U.S. Senate confirmed Merrick Garland as the 86th U.S. attorney general last month, Garland testified that he did not think it was a “useful use” of limited federal resources to prosecute most cannabis-related conduct.

S.B. 888 is not the only cannabis legalization bill being considered in the Connecticut Legislature. House Bill 6377, which emphasizes social equity and includes licensing for social consumption sites and provisions for roadside testing, cleared Connecticut’s Labor and Public Employees Committee, 9-4, on March 25.

But with the Judiciary Committee passing its amended version of Gov. Lamont’s S.B. 888 Tuesday, the two pieces of legislation are now more closely aligned—both measures have been filed with the Legislative Commissioners’ Office.

Stafstrom said, “I would submit that [adult-use cannabis] is long overdue here in the state of Connecticut for a whole host of reasons, not the least of which is that this is a drug that is widely believed to be less addictive and less harmful to the body than many other drugs that we already legalize and regulate here in the state of Connecticut, including tobacco and alcohol.”

Filed Under: Cannabis News

A Look at the Rise Of The East Coast Cannabis Market

April 9, 2021 by CBD OIL

The rise of the East Coast cannabis market gained another foothold in late March 2021 when New York became the most recent state to legalize adult use cannabis, joining ranks with other Atlantic stalwarts, including New Jersey, Maine, Massachusetts, Vermont, Virginia and Washington, D.C.

In doing so, it opened the door to an industry that many experts agree could exceed $7 billion annually, once the market is fully established. That’s potential the cannabis market hasn’t seen since Washington became the first Pacific state to legalize adult use cannabis, almost 10 years ago (followed shortly after by Colorado, then Oregon in 2014 and California in 2016).

Unfortunately, the leaders of this great country have yet to follow suit, and cannabis remains illegal at the federal level. For those in the cannabis market, this means that state-licensed cannabis businesses must cultivate and sell their products within the confines of the state in which they are licensed. Nothing can cross state lines. Even if a business is licensed in both Vermont and New York, it can’t ship product from one state to the other without running afoul of federal legislation. Most in the East Coast cannabis market view this as a negative.

Virginia became the first state in the South to legalize adult use cannabis

While it certainly makes things more difficult, a small group of forward-thinking investors and entrepreneurs see this for what it really is: an opportunity to get in on the ground floor and establish state-specific grow operations and other supply-chain waypoints, where none or few currently exist. Think of the current state of the East Coast cannabis market as a beachhead. Right now, the industry is defined by state lines. But when the federal government finally legalizes adult use cannabis from coast to coast—and it’s only a matter of time before it does—those state lines will essentially disappear. When they do, the beachheads established now will become the infrastructure for the entire Eastern seaboard.

Take Virginia, for example. It shares its border with five states that have legalized medical cannabis but have yet to cross the bridge into adult use sales (West Virginia, Maryland, Kentucky, Tennessee and North Carolina). A Virginia-based grow operation built now has the potential to serve not just those five states but other contiguous markets including Pennsylvania, Ohio, South Carolina, and even Alabama, Georgia and Indiana. A relatively small investment now could pay huge dividends in just a few years, when the market literally blows wide open.

It’s this incredible potential that makes the rise of the East Coast cannabis market one of the most important developments in the last five years. And while the potential scale of grow operations and other cannabis businesses is certainly essential to the conversation, let’s not forget that “niche products” within the East Coast cannabis market are still very much up for grabs.

If the past decade has taught us anything, it’s that consumers are willing to pay a premium for high-quality, organically grown cannabis. Both new and long-time cannabis enthusiasts will choose — even demand — high-quality, organically grown cannabis that looks, smells and tastes fresh and doesn’t rely on harmful fertilizers, heavy metals or pesticides. They’re also enthusiastic about supporting brands that have a commitment to sustainable, eco-friendly operations.

The demand for high-quality, organically grown cannabis continues to increase

It’s very much like the current trends we see in the grocery store aisles. Manufacturers and consumers alike are seeing the value of “whole foods.” After decades of relying on heavily processed fare, both suppliers and end-users are benefiting from higher-quality ingredients. Consumers want to know what’s in the stuff they’re putting into their bodies. When it comes to cannabis, they want to know that what they’re taking to alleviate their anxiety doesn’t include harmful chemicals. This demand has the capacity to push revenue even higher.

And when the dam finally breaks and businesses can ship product from state to state, the idea is for growers to be well-positioned geographically to become suppliers of high-quality, organically grown cannabis, for every state east of the Mississippi.

Cannabis businesses in states such as Colorado have had the past decade to prepare for the coming boom, but that doesn’t mean it’s too late to join the party. The rise of the East Coast market parallels what Colorado and the other Pacific states experienced in the early-to-mid teens—the potential to become a very real industry, with huge capacity for growth and profit. Get in on that action now!

The East Coast cannabis market—and, indeed, the entire U.S. market—also sits on the verge of another game-changing trend: following in the footsteps of other markets and realizing sooner rather than later that high-quality, organically grown, eco-friendly cannabis is the next stage of the game. Few investors and entrepreneurs see that right now, but the astute businessperson can capitalize on both trends now and position themselves and their businesses for huge returns in the very near future. The rise of the East Coast cannabis market makes that a very real possibility.

Filed Under: Cannabis News

Virginia Accelerated Its Legalization Plans. What’s Next?

April 9, 2021 by CBD OIL

Buckeye Relief | buckeyerelief.com

The Buckeye Relief infused-foods team, including Kitchen Manager Emily Rollo (front left), Executive Chef Marc London (front right), Kitchen Tech Lupe Rivera (back row, from left), Kitchen Tech Ricardo Yepez and Assistant Kitchen Manager Ryan Fatica, carefully craft a line of cannabis edibles with a focus on taste and effectiveness.

The first time Marc London received a complaint about the taste of his chocolate, there was only one response he deemed appropriate.

“Thank you,” said London, the executive chef at Buckeye Relief, a medical cannabis cultivator and processor in Eastlake, Ohio, about 15 miles northeast of Cleveland, where he and Kitchen Manager Emily Rollo carefully craft infused foods with a focus on taste and effectiveness. Their line of edibles includes chocolates; locally sourced honey; Wana gummies; and Keef Brands, an infused beverage available in lemonade and strawberry kiwi.

Tony Lange | cannabisbusinesstimes.com

Buckeye Relief’s 25,000-square-foot indoor grow facility became operational in July 2018 in Eastlake, Ohio. 

Buckeye Relief, which has a 25,000-square-foot indoor grow facility that became operational in July 2018, launched its kitchen operation shortly after getting an extraction license in the spring of 2019. While Ohio legalized medical cannabis in 2016, statewide sales didn’t begin until early 2019.

An executive chef by trade, London always worked with chocolate when he owned a prepared-foods store and a catering business in the mid-80s, he said. Since London believes chocolate is one of the most complex food products on the planet to work with, he made it his mission to search high and low for the best commodity on the globe to infuse, he said.

Buckeye Relief co-founders Andy Rayburn, CEO, and Scott Halloran, chief operating officer, began the planning phases of their company in 2016, shortly before Ohio’s passage of medical cannabis House Bill 523—two years before Buckeye Relief became operational—which provided London ample time to track down the right chocolate for the operation.

“I was even down in Ecuador looking at chocolates down there, because I think Ecuador is one of the best producers of chocolate in the world, even though most of our chocolate comes from South Africa,” London said. “And I just happened to be in Ecuador, so … I just started doing some research down there and brought some back here.”

Tony Lange | cannabisbusinesstimes.com

Buckeye Relief offers a 72% cacao dark chocolate, a smooth and creamy milk chocolate and a 1-to-1 ratio marble chocolate year-round. 

While his prospects from Ecuador showed promise, London and his team at Buckeye Relief eventually decided on a Belgian chocolate to infuse in their kitchen. They now offer a 72% cacao dark chocolate, a smooth and creamy milk chocolate and a 1-to-1 ratio marble chocolate, as well as seasonal flavors, like a white-minted chocolate with sprinkles during December holidays.

Key to Buckeye Relief’s line of infused foods is the kitchen’s focus on producing edibles that don’t have the flowery or grassy taste of the cannabis plant, and that goes for all of the edibles, not just the chocolate, London said. “I wanted products that tasted just like the ingredients that went into it with the exception of the extraction ingredients,” he said.

In turn, London steered clear from compound chocolate, which can be melted down and deposited into molds without being tempered, and put his attention on “real” chocolate, which requires the breaking down of fats and waxes before being tempered back to its original state with the cannabis extract infused, he said. The end product retrieves a nice, glossy finish, he said.

“When you look at really good chocolate, you’re like, ‘Wow, that is beautiful,’” London said.

He and his team—which, along with Rollo, also includes Assistant Kitchen Manager Ryan Fatica and kitchen techs Lupe Rivera and Ricardo Yepez—were not just after an infused chocolate that had good health benefits, but a product that both presented itself well and had great taste, he said.

So, when Buckeye Relief Communications and Marketing Director Leslie Brandon notified London that she received a complaint about the taste of his chocolate, specifically regarding how one consumer “could not taste the cannabis” in the product, there was only one response he deemed appropriate: “Thank you.”

“And that’s literally happened numerous times where I’ll get emails from Leslie, ‘Marc, we just got a complaint. They can’t taste anything in the chocolate,’” London said. “And the first time she ever sent that to me, I just emailed her back, ‘OK, I’m going to take that as the ultimate compliment, because that’s what I set out to achieve from day one.’”

London also attributed the taste of Buckeye Relief’s chocolate to the extraction team’s understanding of how to process a cleaner and redefined end product from the plant to infuse into the edibles, he said.

Planting Their Roots

Still in its infancy, Ohio’s medical cannabis program has more than 176,000 registered patients as of Feb. 28, 2021, according to the Ohio Medical Marijuana Control Program. On the retail front, Ohio averaged $5.7 million in total product sales per week through the first 10 weeks of 2021, compared to an average of $2.5 million per week during the same timeframe in 2020, according to the control program.

But London and Rollo’s connection to cannabis and to the kitchen extends beyond Buckeye Relief. Friends with Rayburn for more than 30 years, London’s first customer for his catering business in the ‘80s was Rayburn’s ex-wife, he said.

“That’s how I met Andy, and what bonded us was our love of music, live music, and our love for sports,” London said. “I’ve seen over 250 [Grateful] Dead shows in my life. A hundred of them were probably with Andy. And we haven’t stopped yet. So, when we had that jam-band connection, that carried us through all these years. We’ve gone all over the place. It’s great.”

On Dec. 5, 2018, the night before Buckeye Relief’s first harvest and the plants’ last night in the flower room, Rayburn gave the crop a special treatment. He played the Grateful Dead’s legendary 1977 concert at Cornell University’s Barton Hall over the PA system, making sure the plants had a “good last evening,” Rayburn said.

RELATED ARTICLE: Buckeye Relief’s First Harvest in Ohio’s Medical Marijuana Market

After his prepared-foods store and catering business, which he transitioned into a smoothie juice bar operation, London went on to extend his expertise in the publishing industry, where he built a Cleveland-based magazine called Fine Lifestyles that shared editorial about the people, cultures and businesses that make up Northeast Ohio.

London said he’d still be running that magazine if it were not for Rayburn.

“I’d still be in that business if Mr. Andy Rayburn hadn’t said, ‘Marc, I think I’m going into the cannabis business,’” London said. “And I heard that and said, ‘OK, well, if he’s going in the cannabis business, then I’m going into the cannabis business—just let me know when and where.”

Once Buckeye Relief built its facility and started its grow, it was just a matter of time before the company received its extraction license and opened a kitchen for infused foods. Until then, London sometimes helped out in other facets of the operation, including trimming plants. That’s where he first crossed paths with Rollo.

Intern to Kitchen Manager

Tony Lange | cannabisbusinesstimes.com

Buckeye Relief Kitchen Manager Emily Rollo got her start as an intern in the trim department in 2018. 

Rollo first started working at Buckeye Relief as an intern in the trim department in 2018, an entry-level, yet important phase of cannabis cultivation.

Working in the restaurant industry for five years to help put herself through college, Rollo graduated with a bachelor’s degree in liberal arts and earned a certificate in non-profit leadership, before starting a short career in the advertising industry, where she worked sales and marketing.

During that time, Rollo had a grandmother who struggled with opioids and being able to control her doses, she said. That was around the same time Ohio passed its medical cannabis bill, which sparked Rollo’s interest in researching related opportunities before networking and eventually getting her foot in the door at Buckeye Relief, she said.

“I came from working in the advertising industry, which I really loved my job,” Rollo said. “I really enjoyed it. But I wasn’t feeling fulfilled, you know, I wanted to help people and I wanted to feel like I had that purpose.”

Once in the door, Rollo’s journey shifted toward making herself standout among 30-some interns in the trim department, she said.

“I had to create a system for myself and a strategy for myself to kind of set myself apart and start networking with people,” Rollo said. “I spotted Marc in the trim room and just started talking to him, chatting with him. Over conversation, I was able to figure out his history—I didn’t know at that point that he was in charge of the kitchen. I didn’t know at that point that he was hired in. I just knew that he was back there helping us trim.”

Diving deeper into conversation with London and picking his brain about his expertise and his soon-to-be kitchen operation, Rollo quickly went from intern to kitchen manager in roughly a year. Through her desire to be on a team that provides edibles for patients in Ohio, Rollo travelled out to Colorado with London in July 2019 to train under experts from Wana Brands, a U.S. leading infused-products company known for its gummies.

Gummy Trends

Shelby | Adobe Stock

Cannabis-infused gummies are the most popular edible in the U.S. 

According to cannabis market research expert BDSA, a consumer insights data report from September 2020 revealed that infused gummies made up 84% of candy ingestible sales at that point in the year across Arizona, California, Colorado, Nevada and Oregon. In addition, 60% of U.S. edible users reported consumption of infused gummies, while baked goods were the second most popular ingestible product at 46%. And 33% of U.S. ingestible consumers cited gummies as their preferred type of edible, with a 15-point margin over baked goods as the next most popular preferred ingestible product.

“Seeing how the sales trends go, as legalization spreads throughout the United States, I saw this big opportunity that this is going to be the future of the industry,” Rollo said. “This is going to be the future of dosing. People, especially the older generations, love how convenient it is. You don’t have to smoke it. It’s something you can keep in your pocket and dose throughout the day. So that is kind of what really, really sparked my interest in that part of the industry, [where] I really saw myself thriving.”

After their weeklong training with Wana in Colorado, Rollo and London received additional hands-on instruction from Wana experts, who flew out to Ohio for detailed recipe explanations at Buckeye Relief.

And in order to meet testing standards in Ohio, Rollo said she and the Buckeye Relief team fine-tuned their gummy trials for maybe six to nine months before finally dialing in their operation. Now, a team of three to four people in the kitchen can produce anywhere from 20,000 to 30,000 gummies in a typical day, Rollo said.

In order to be more efficient, the kitchen team sometimes operates in longer shifts, working from Monday through Thursday, so that it only has to go through the time-consuming processes of setting up and cleaning up four times in a week rather than five times, Rollo said.

“I am extremely passionate in every single batch that I make, you know, my passion shows through it,” she said. “So definitely the gummies [are my passion], cause it’s kind of in my heart and soul from the beginning. I kind of had to go through a lot of testing issues, you know, to kind of get that formulation correct on it for probably six to nine months until we really dialed it in. So, yeah, it’s been a journey.”

The Buckeye Relief kitchen team produces several different cannabidiol (CBD)-to-tetrahydrocannabinol (THC) ratios in gummies. For example, there’s a five-to-one pomegranate blueberry acai gummy that has 25 milligrams of CBD to 5 milligrams of THC, which is popular among people who haven’t tried edibles before and are interested in the micro-dosing market, Rollo said. And then there are strawberry lemonade and watermelon flavors that include a one-to-one ratio of 10 milligrams of CBD to 10 milligrams of THC, while more exotic flavors, like yuzu, offer a two-to-one ratio.

Meanwhile, Buckeye Relief also produces gummies that are straight THC, including 10-milligram pieces as well as a new macro line of 30-milligram gummies in raspberry-limeade and blood orange flavors, which are for the more experienced consumers, Rollo said.

The specific flavors come from proprietary blends of terpenes—aromatic compounds found in many plants, including cannabis—that are picked out by Wana, Rollo said. In addition to flavoring, terpenes also provide different effects, she said.

“So, the mango is more of the sativa, which has the uplifting effects,” she said. “Indica more for the asleep. And hybrid obviously for a little bit of both.”

Attention is in the Details

When it comes to creating products that not only land on the shelves at dispensaries, but also stay on those shelves, Rollo and London both said their efforts boil down to running a detail-oriented operation.

Tony Lange | cannabisbusinesstimes.com

Buckeye Relief’s flower room includes several cannabis varieties. 

“We operate exactly like any other [non-cannabis] medical facility in the state of Ohio,” Rollo said. “We want to make sure that we have a professional representation of how we operate. We’re trying to prove ourselves in some ways, showing that we are this legitimate business, and this is a medicine that helps people.”

On the edibles side of the industry, London said his team treats infused foods like artisanal products. For example, one batch will generate 700 gummies—only a fraction of a daily production. But rather than use a bigger cooking pot, the team at Buckeye Relief controls the quality of each gummy by simply producing more batches, London said. The same dialed-in concept applies to chocolates, he said.

“I could take a giant chocolate tank of 200 gallons of chocolate and fuse the whole thing and then start pumping it out,” he said. “I am not going to end up controlling the quality or the potency the way I can in a 15-pound run.”

Each 15-pound run will produce about 120 bars of chocolate, London said. If market demand increased beyond Buckeye Relief’s current output, then the best avenue to scale up production and maintain the quality of the brand would be to train more staff to handle more runs, he said.

Another factor pertaining to chocolate, especially the volatility of milk chocolate, is humidity, which can create a bloom, or a white, shadowy appearance that puts an eyesore on the presentation to each bar, London said.

“Up until this past summer, when I put new dehumidifiers in here, I had to produce a lot of my milk chocolate in the springtime,” he said. “There’s just too much moisture in the [summer] air. You can’t get it to cool down properly and harden properly. So, it really, it’s not as much what we produce on a daily/weekly basis, but it’s how do we control it so we can put out the highest quality year-round.”

Buckeye Relief also has a brand of locally sourced raw honey that is harvested using natural methods and then infused with a little extra buzz. While the company has its own beehives, it doesn’t have enough to keep up with demand. In turn, Buckeye Relief connected with a local beekeeper from Bainbridge Township, in neighboring Geauga County, who provides a few hundred gallons of honey any time the kitchen needs it, London said.

And then Buckeye Relief’s line of Keef—a brand in the cannabis beverage space that was originally launched in 2010 in Boulder, Colorado—includes a strawberry kiwi beverage that tastes similar to flavored water and a lemonade that tastes like a powdered-beverage mix, London said.

“I think the market is going to really, really enjoy it,” he said. “If I was making that beverage and when you drank it you were like, ‘Oh my, god. What’s that bitter, nasty plant taste?’ we would never have that product here at Buckeye Relief.

“One of the things is, we have worked really, really hard for shelf space at dispensaries. So, our commitment is, we worked so hard to get it, we can’t lose that shelf space, which means we need to be able to duplicate and produce enough to never run out. And some products just aren’t designed for that.”

Filed Under: Cannabis News

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 50
  • Go to page 51
  • Go to page 52
  • Go to page 53
  • Go to page 54
  • Interim pages omitted …
  • Go to page 116
  • Go to Next Page »

Footer

  • Home
  • Privacy Policy
  • Terms of Service